% | $
Quotes you view appear here for quick access.

OneBeacon Insurance Group, Ltd. Message Board

snogreen 127 posts  |  Last Activity: 17 hours ago Member since: Aug 30, 2000
SortNewest  |  Oldest  |  Highest Rated Expand all messages
  • Here's another classic by Finnel Tinkel and why no one believes RGRX. Teh release todays states VERY clearly that RGRX is forced to IN LICENSE the rights FROM HENRY FORD for this IP. But all along RGRX has also had to in license the compound from the NIH. WHY does RGRX have to in license TB 4 for neuro from Henry ford? They deserve something for their work, but I woudl like to know why they got the patent in the first place. because US Patent 8,716,215 issued to RGRX over a year ago very clearly shows that RGRX was first in line for neuro related TB 4 IP. So why did Henry ford get it? And why does RGRX have to IN LICENSE it from henry ford, when RGRX is already "in licensing" TB 4 from the NIH?

    SEE? It is why no one trusts RGRX. And we are valued where we are. No one trusts Finkelstein. He hides the June 16 heart issued patent and he won't explain why Henry ford is able to step OVER RGRX's already granted neuro patent

  • Reply to

    Pr out

    by piano.man5 Jul 14, 2015 12:55 PM
    snogreen snogreen Jul 14, 2015 1:21 PM Flag

    Oh, just in case you wish to look at other USA patents issued to RGRX in teh heart area..look at no#'s 8,426,365 and no# 8,093,214.

    Still silence on June 16 one.

  • Reply to

    Pr out

    by piano.man5 Jul 14, 2015 12:55 PM
    snogreen snogreen Jul 14, 2015 1:12 PM Flag

    The USA heart patent was issued in June 16, 2015...just less than one month ago. Silence and RGRX hides they got it.

    If you do not believe me, go to US Patent Office main site. Go to patent search. You can search by the patent NUMBER..which is 9,056,087...or you can just search in issued patents Thymosin beta.

    Silence. It's why no one trusts Finkel Tinkel and why no one really cares much about the PR today. because RGRX altready HAS A PRETTY GOOD USA patent for euro area. That issud patent number is 8,716,215 if you care to look for yourself.

  • Reply to

    today would be a good time for news release

    by thebasiles777 Jul 13, 2015 6:51 AM
    snogreen snogreen Jul 14, 2015 6:23 AM Flag

    The July and August time periods have always been a slow time for comp[anies to try and do PR or news stuff. Markets are generally slow and it is high vacation time in the buy and sell side world.

    No better example of this is that RGRX got a major, major USA patent in the heart are.....and RGRX stays silent. HELL! RGRX always hypes they get a patent when they get them in Canada, mexico or China. for instance. One of the knocks on RGRX has been they have a hard time in USA patents. And partner big pharma wants protected IP in USA before they invest big money. So what does Finkel Tinkel do? stay silent, hide it....but just after we get the USA patent in heart, he issues himself 500,000 free of the largest gratnts, ever, to him I think. he desrves some, but not that much. for what? SILENCE???

  • Reply to

    Cargill pork sold

    by snogreen Jul 2, 2015 2:21 PM
    snogreen snogreen Jul 13, 2015 4:57 PM Flag

    Few days ago Bloomberg did article w/ Perdue. 3rd largest chicken. Perdue said they get calls all teh time to sell, but they aren't interested. JBS buys Cargill pork. Chines byu Smithfield. Tyson buys Hillshire. perdue not interested selling. Overseas buyers looking. SEB is 2nd or 3rd largest total processor pork. Desireable for long haul. China will pick up again. Also SEB owns up to 55% of Butterball. That has turned around. I bet JBS woudl LOVE to buy Butterball....then JBS is tops in chicken, pork, beef and turkey. I'd guess SEB's 55% stake with debt B Ball owes SEB woudl be worth about $750 million. SEB could peel that off easily. If buyers calling Perdue all time, they are calling Butterball.

  • Reply to

    119,000 volume, 96,000 shorted

    by snogreen Jul 10, 2015 9:17 AM
    snogreen snogreen Jul 10, 2015 4:50 PM Flag

    nahh. it's the MM shorting. Most likely all ny NITE. GTree wouldn't sell.- They'd risk SEC issues of disclosure. G Tree stock is up so much BECAUSE of the USA stuff they now have in TB 4. Why woudl they risk it all by cheating and selling stock, when they own 20% of RGRX and then not report that to SEC? If G Tree selss a SINGLE SHARE, they have THREE business days to filke w/ SEC. big risk. And who woudl approved TB 4? Another govv't agency, the FDA.

    Same goes with RGRX mgmt selling overseas & not reporting as an insider sale. Not worth SEC risk. Besides, Goldstein is actuallyy GIVING and GIFTING a lot of his stock AWAY.... (in 2014 & 2015) to someone or some entity.

    Cavazzas & ST aren't selling. they own about 30%. They won't risk SEC or gov't risks either, because ST has a decently large USA divison which is also under gov't regulations with teh FDA. Why woudl they risk the ire if SEC? To seel stock at 40 cents that ST bought a LOT higher? Makes no sense.

    MArket makers are short 2-3 million RGRX, IMO.....and they are naked short because they are exempt from SEC rules of borrowing or reporting their shorts.... for the MM book. But teh scam and illegal thing NITE doies is use the MM exemption for a LONG TERM POSITION trade to evade rules, as opposed to teh exempt rule for a MM to only do so in the course of daily buy/sell/buy/sell. All NITE does ususally is SELL, SELL, SELL and SELL.

  • Wednesday there was over 50% of RGRX shorted. yesterday (Thursday)...82% of all volume was shorted. 119,000 shares traded, 96,000 was shorted. It is no wonder RGRX can never rise. And the dopes at the SEC report that the latest is about a grand total of 2,900 short in RGRX. In just the last two trading days, about 150,000 RGRX was shorted. By the market makers. They neither have to report what they are short to the SEC, nor do they have to borrow shares they are short. In essence, they are just naked short. And they are naked short a whole lot of RGRX as a POSITION trade, but not in the "ordinary course of making a daily market". They make a massive TRADE bet, not a buy/sell market maker activity. And they cheat the rules of SEC to do so. CAn't argue the facts. We see what teh SEC reports as short. We see what FINRA reports is shorted daily. The figures are MILES, and MILES apart.

  • Reply to

    New US heart patent, June 15. Hidden by RGRX.

    by snogreen Jul 10, 2015 6:43 AM
    snogreen snogreen Jul 10, 2015 7:02 AM Flag

    Also note this...RGRX officially got the patent on JUNE 16 (they were notified in late May though). On JUNE 15, RGRX filed a confidential treatment filing oder (CT Order) with the SEC. Perhaps it had something to do with the patent just gotten but NOT disclosed? Then on JULY 2, it hits the SEC filings that Finkelstein gave himself (he tells the BOD what he wants) 500,000 free options at $0.36.

    if he has any honor & integrity, he should release this very big new heart USA Patent news, and then TWO DAYS AFTER that release, his 500,000 free stock options SHOUD BE RE PRICED where RGRX closes. then AFTER the news is released as it should have. It reeks of Finkelstein self dealing greed that he got 500,000 optiomns while he knew material patent news, but the stock holders (and thus share price reflection of) did not.

  • Here is the exact info for the patent issued JUNE 16, 2015

    "United States Patent 9,056,087
    Goldstein , et al. June 16, 2015
    Methods of healing or preventing inflammation, damage and other changes that occur prior to, during or immediately after a myocardial event with thymosin beta 4, analogues, isoforms and other derivatives ."

    We alreayd have one or two heart related US Patents, but this seals the deal. Same with the neuro area.....with Henry Ford getting one, and RGRX did earler in 2014.

    What REALLY, REALLY, REALL, REALLY stinks of this new heart patent is that I checked and RGRX was notified in late MAy they got it.....then a couple weeks formalites and paperwork and on June 16 all is done. but RGRX deemed this major aditional heart USA patent was not "material" news. It is. But go back 10 days ago. RGRX and the Board must have had a meeting because they gifted out the freebies. In this case Finkelstein got himself 500,000 free stock options. That is a BIG grant. More than usual. Don't you all see how it reeks? He got those options on July 1 or when the Board met......but this pretty big USA PAtent news came June 16. He his it while he got his 500,00 options. It is now July 10 and RGRX refuses to disclose this patent new. In the meantime Finkelstein get's his optionspriced below where the stock is nos and BEOW where this 'See Equity" group, which FINKELSTEIN IS PAYING.

    Go read the patent. Another example of Finkelstein incompetance and greed. He'll probably have to do a release on it now. I expose him as hiding big news, and I have done so before.

  • Typical RGRX. The PAtent Ofice granted FINALLY RGRX another USA patent in heart area. Preyy big. HAppened in mid June. RGRX is silent and not disclosing this.

    The Henry Ford patent os okay, but RGRX already has a close neuro one issued previously. Gues smore is better. This will aid Dr. Chopp if he has any ideas for a partner. He has a good reputation. But no pharma is really interested unless you got teh patent protection. So right now, we have TWO in neuro are (with HF) and I think three in the heart area.

    The LATEST heart patent was FILED IN 2001. That shows you how much of an SOB the USPO os......FOURTEEN YEARS OF FIGHTING THEM, and now they gove in.

    If you want to look, the patenet publication number is 20040258680

    RGRX received this THREE weeks ago and it hiding it.

  • I see that Alergan (AGN) is buying an early stage dry eye "device" company called occlusive, for $125 million. They claim a 2 part device that you shove up your nse and a second implanted by your eyebrow, which they hope will create more tears. Seems a hard way abouyt implant and one shoved up your nose. And creating tears does not heal the cornea, which TB 4 hopes to. Allergan knows Ora very well. And Ora knows TB 4 and RGRX very well. So why didn't AGN look at TB 4?

  • Reply to

    awaiting news

    by thebasiles777 Jul 6, 2015 9:21 AM
    snogreen snogreen Jul 6, 2015 9:38 AM Flag

    there is no news to speak of. The two USA trials won't start till late in year or even early 2016. The only other sooner news, trial wise, is China....but we are on a slow boat to no where on that front. Something isn't right with Lee's. It has been over three years since they did their TB 4 deal, and they appear to have no interest in it..or at best, it is on a way back burner.

  • JBS bought Cargill's pork ops. That leaves SEB as the only large stand alone big priok processor left. JBS already owns Swift pork and they just took Cargill.........Tyson is big in pork and they aren't selling.and Chinese bought Smithfield for $7.1 billion

    Only one big player independant left....SEB.

  • snogreen snogreen Jun 29, 2015 8:22 PM Flag

    Thanks for sharing, but no one cares anymore WHAT RGRX throws out into the press. Once burned thrice learned...After 20-55 years of hundreds and hundreds of similar great reading abstracts...what has changed? Nothing --- except RGRX was almost bankrupt.....they've #$%$ thru close to $100 million..and we have a 30 cent stock. Same old.... same old. waiting and waiting and waiting on another trial.. THE ONLY THING THAT CAN CHANGE RGRX IS GETTING THE F TRIALS STARTED. Seems like Lee's in China is taking RGRX for a ride.

  • Reply to

    Since June 2nd

    by thebasiles777 Jun 25, 2015 8:35 AM
    snogreen snogreen Jun 25, 2015 12:06 PM Flag

    I toled you there is no PR really. PR's on abstracts mean squat. Any new one abstract can just joing teh hundreds of others on Tb 4...i a trash can , as far as Wall St is concerned. I have no qulams of teh timing of teh 2 USa trials. I feel good Ora is on it. The eye NK trial will be a complcated one. Ora has never done one. It will probably be multi center..and all has to be designed & approved by FDA.......working with Ora, koreans and RGRX. teh dry eye one will be easier...but still need endpoint approval. Also, Ora is already tied up with a dry eye trial. I don't think you see a trial start on these till fourth quarter...and teh eye NK may even be later......the hardest thing of a trial, ESPECIALLY a Phase 3, is teh patient selection. Ora wants to they will fo it right and it may not be as easy as we think to get teh right patients. It may take 4 or 5 centers to finsd them....and it is harder for Ora to control and moitor the pts too.

    China is the one that gets me grumpy. It sure looks liek Lee's is playing Finkel for a chump. I was hopeful for a trial start there FIRST in Q2....because that will finish first. And is a trial win there..RGRX will zoom..because it will bode well for USA ones.


  • Reply to

    no ticket

    by snogreen Jun 22, 2015 1:52 PM
    snogreen snogreen Jun 22, 2015 1:56 PM Flag

    Too scrubbed & cleansed the above post........the changed teh last two letters of the words and removed "ee". Too funny,

  • snogreen by snogreen Jun 22, 2015 1:52 PM Flag

    no shirt

    no movee

    It's over one year sime Lee's got prelim for trial filing.......nothing. It's over three years since they signed the 'deal'. I don't understand why Finkel can't just ask them.....'what if going on".

  • Reply to

    at .35

    by thebasiles777 Jun 19, 2015 11:10 AM
    snogreen snogreen Jun 19, 2015 12:00 PM Flag

    this is where you lose it.....

    " the co-ceo has said $16 mil net should be realized in 2016 from this deal...."

    In about 6 months it will be 2016. How can the guy say that? not a SINGLE trial has even started.not in Korea, not in China, not in US. This dud better be careful what he the USA, if he said such and it didn't happen.......he'd get sued. How can you hype REVENUE, when you haven't even started a trial? or finished a trial..or gotten results....or filed for approval.......or gotten approval?

    This is exctly the kind of hype the MM's love to short into.

  • Reply to

    shorts in control here

    by snogreen May 28, 2015 11:53 AM
    snogreen snogreen Jun 18, 2015 2:46 PM Flag

    Actually, while Butterball got hit in some places, Jennie-O-Turky got hit harder up in MN. If Butterball flocks did not get hit as bad..we all know turkey prices went UP. The higher price will benefit B Ball. Further, you have not checked teh price of CORN...whichj went BELOW 43.50 a is down pretty hard last month or so......and DOWN FROM $7.00 a bushel a cpouple years ago! LOW FEED PRICES INCRESSE PROFITS.

    Thos that paint a disaster because of flu, may not be right. SEB is cheap. besides, SEB DOES NOT OWN Butterball....they own 50%!!!

  • I don't think you'll get much news as you hope. It is not in Alleghany's best interest to shout to the world if it works as hoped. Why? Simple. if it does work, Y will see it could be a long term home run. But they only control three small fields. If it works in Kansas (first field).......Then Y woudl probably move ahead to buy more fields earmarked by LRDC. Plenty of high cost EOR fields woudl be available at a decent price. if Alleghany shouts to the world.."EUREKA....WE STRUCK GOLD" (i.e. UGD oil from underneath).....then what do you think will happen to the prices of the possible fields for sale??/ PRICE GOES UP! Now is the perfect time to buy expensive and aged fields, ON THE CHEAP LOWDOWN!. peopelewant OUT of them. But they won't sell as cheaply if Alleghany and LRDC hypes it to the world that a small Kansas field "struck gold" for them. Very simply, it is called a "tight well" Y will not talk, hype or do PR. And Y contract says they get back their over $200 million FIRST. Royalty a long way off LRDC.

13.78-0.27(-1.92%)Sep 4 4:01 PMEDT